{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:36:39Z","timestamp":1788255399434,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000009042","type":"journal-article","created":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T22:05:35Z","timestamp":1511906735000},"page":"e9042","source":"Crossref","is-referenced-by-count":28,"title":["Assessment of change in glucose metabolism in white matter of amyloid-positive patients with Alzheimer disease using F-18 FDG PET"],"prefix":"10.1097","volume":"96","author":[{"given":"Young Jin","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Young","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-101-20210226","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"R2-101-20210226","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J Neurosci"},{"key":"R3-101-20210226","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/glia.10146","article-title":"Neuroinflammation in Alzheimer's disease and prion disease","volume":"40","author":"Eikelenboom","year":"2002","journal-title":"Glia"},{"key":"R4-101-20210226","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology"},{"key":"R5-101-20210226","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"R6-101-20210226","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement"},{"key":"R7-101-20210226","first-page":"792","article-title":"An early and late peak in microglial activation in Alzheimer's disease trajectory","volume":"140","author":"Fan","year":"2017","journal-title":"Brain"},{"key":"R8-101-20210226","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.nbd.2008.08.001","article-title":"Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study","volume":"32","author":"Edison","year":"2008","journal-title":"Neurobiol Dis"},{"key":"R9-101-20210226","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci"},{"key":"R10-101-20210226","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/npp.2012.255","article-title":"Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia","volume":"38","author":"Edison","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"R11-101-20210226","first-page":"CD006378","article-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease","volume":"2","author":"Jaturapatporn","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-101-20210226","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-141506","article-title":"Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis","volume":"44","author":"Wang","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"R13-101-20210226","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jalz.2014.08.105","article-title":"Imaging neuroinflammation in Alzheimer's disease and other dementias: recent advances and future directions","volume":"11","author":"Varley","year":"2015","journal-title":"Alzheimers Dement"},{"key":"R14-101-20210226","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/glia.22357","article-title":"Molecular imaging of microglia\/macrophages in the brain","volume":"61","author":"Venneti","year":"2013","journal-title":"Glia"},{"key":"R15-101-20210226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.114.141713","article-title":"Imaging microglial activation with TSPO PET: lighting up neurologic diseases?","volume":"57","author":"VivashL","year":"2016","journal-title":"J Nucl Med"},{"key":"R16-101-20210226","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1742-2094-11-120","article-title":"Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging","volume":"11","author":"Zimmer","year":"2014","journal-title":"J Neuroinflammation"},{"key":"R17-101-20210226","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2967\/jnumed.115.167858","article-title":"Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer PET study","volume":"57","author":"Brendel","year":"2016","journal-title":"J Nucl Med"},{"key":"R18-101-20210226","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.23356","article-title":"Glucose pathways adaptation supports acquisition of activated microglia phenotype","volume":"92","author":"Gimeno-Bay\u00f3n","year":"2014","journal-title":"J Neurosci Res"},{"key":"R19-101-20210226","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/mds.23291","article-title":"Typical cerebral metabolic patterns in neurodegenerative brain diseases","volume":"25","author":"Teune","year":"2010","journal-title":"Mov Disord"},{"key":"R20-101-20210226","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1148\/rg.343135065","article-title":"Brain PET in suspected dementia: patterns of altered FDG metabolism","volume":"34","author":"Brown","year":"2014","journal-title":"Radiographics"},{"key":"R21-101-20210226","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cpet.2013.10.006","article-title":"Brain: normal variations and benign findings in fluorodeoxyglucose-PET\/computed tomography imaging","volume":"9","author":"Berti","year":"2014","journal-title":"PET Clin"},{"key":"R22-101-20210226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00294459","article-title":"White matter amyloid in Alzheimer's disease brain","volume":"90","author":"Uchihara","year":"1995","journal-title":"Acta Neuropathol"},{"key":"R23-101-20210226","first-page":"83","article-title":"Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity","volume":"2","author":"Collins-Praino","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"R24-101-20210226","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"R26-101-20210226","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/YCO.0b013e32835ed6e8","article-title":"Is Alzheimer's a disease of the white matter?","volume":"26","author":"Sachdev","year":"2013","journal-title":"Curr Opin Psychiatry"},{"key":"R27-101-20210226","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00207454.2015.1025778","article-title":"Oligodendrocytes and Alzheimer's disease","volume":"126","author":"Cai","year":"2016","journal-title":"Int J Neurosci"},{"key":"R28-101-20210226","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","article-title":"Mechanisms of A\u03b2 clearance and degradation by glial cells","volume":"8","author":"Ries","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"R29-101-20210226","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/13550280290100969","article-title":"Local neuroinflammation and the progression of Alzheimer's disease","volume":"8","author":"McGeer","year":"2002","journal-title":"J Neurovirol"},{"key":"R30-101-20210226","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1097\/00001756-199909290-00007","article-title":"Mapping biochemistry to metabolism: FDG-PET and amyloid burden in Alzheimer's disease","volume":"10","author":"Mega","year":"1999","journal-title":"Neuroreport"},{"key":"R31-101-20210226","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jalz.2014.06.016","article-title":"Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia","volume":"11","author":"Fan","year":"2015","journal-title":"Alzheimers Dement"},{"key":"R32-101-20210226","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00259-010-1612-0","article-title":"In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease","volume":"38","author":"Yokokura","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R33-101-20210226","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R34-101-20210226","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"R35-101-20210226","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm0196-93","article-title":"Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome","volume":"2","author":"Teller","year":"1996","journal-title":"Nat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:45:42Z","timestamp":1620960342000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712010-00101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":34,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009042","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}